A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection.

Shahid HusainAndrew T SageLorenzo Del SorboMarcelo CypelTereza MartinuStephen C JuvetAndrea MariscalJulie WrightBonnie T ChaoAlaa A ShamandyS Hossein MousaviJin MaBo WangJerome ValeroMingyao LiuMegan LandesSharaniyaa BalachandranKimberley HudsonMichelle NgaiMarialessia CapuanoMaria GelardiEnrico LupiaDaniel R MarinowicFrederico O FriedrichCarine R R SchmitzLeticya S M Dos SantosFlorencia M Barbe-TuanaMarcus H JonesKevin C KainTony MazzulliSam SabbahShaf Keshavjee

Published in: The European respiratory journal (2022)

The rapid diagnostic biomarker panel accurately identified the need for inpatient care in patients presenting with respiratory symptoms, including COVID-19. The RALI-Dx test is broadly and easily applicable across many jurisdictions and represents an important diagnostic adjunct to advance emergency department decision-making protocols.

Keyphrases

respiratory tract
emergency department
decision making
palliative care
coronavirus disease
sars cov
healthcare
sleep quality
high throughput
mental health
quality improvement
physical activity
single cell